| |
| Device | Paradigm™ Real-Time Revel™ System |
| Generic Name | Sensor, glucose, invasive |
| Applicant | Medtronic Minimed 18000 Devonshire St. Northridge, CA 91325 |
| PMA Number | P150019 |
| Supplement Number | S064 |
| Date Received | 11/17/2021 |
| Decision Date | 12/17/2021 |
| Product Codes |
MDS OYC |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01464346
|
| Supplement Type | Special (Immediate Track) |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval for a labeling update to provide additional clarity on an existing warning for acetaminophen interference to the continuous glucose monitoring (CGM) component of the system. |